Depletion of Central Memory CD8⁺ T Cells Might Impede the Antitumor Therapeutic Effect of Mogamulizumab

The authors showed that despite a significant reduction in peripheral effector Treg cells, clinical responses are minimal in a cohort of patients with advanced CCR4-negative solid cancer in a Phase Ib study.